- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterFriday, November 4, 2005
OncoLink's daily online reports from the Chemotherapy Foundation Symposium in New York City on November 2-5, 2005. |
|
Bevacizumab/Erlotinib Combinations in the Treatment of Metastatic Renal Cell Carcinoma (RCC)
Presenter: John D. Hainsworth, M.D.Presenter's Affiliation: Sarah Cannon Research Institute, Nashville, TNType of Session: ScientificBackground Most clear cell renal cancers have mutations or inactivations of the von Hippel Landau (VHL... |
|
|
Docetaxel Combination Therapy in Prostate Cancer
Presenter: Daniel Petrylak, MDPresenter's Affiliation: Columbia University, New York, New YorkType of Session: ScientificBackground SWOG 9916 compared doctaxel/estramustine to mitoxantrone/prednisone for patients with metastatic,... |
|
|
Motexafin Gadolinium (MGd): Targeting Oxidative Stress Pathways for the Treatment of Non-Hodgkin's Lymphoma
Presenter: Andrew M. Evans, DO, MSCIPresenter's Affiliation: Northwestern University, Chicago, IllinoisType of Session: ScientificBackground Motexafin Gadolinium (MGd or Xcytrin) is a novel anti-cancer agent which disrupts redox- dependent... |
|
|
Oral Topotecan Plus Supportive Care Offers Survival Benefit Compared To Supportive Care Alone
Presenter: Mary O'Brien, MDPresenter's Affiliation: Royal Marsden Hospital, UKType of Session: ScientificBackground Controlled, randomized trials are considered the gold standard of evidence-based medicine. For patients (pts) with... |
|
|
Pemetrexed in Extensive Stage Small Cell Lung Cancer
Small cell lung cancer (SCLC) represents about 20% of all lung cancers diagnosed in the US, with about 25,000 to 30,000 new cases each year. Of these cases, about two-thirds are considered "extensive stage" (ES), and combination... |
|
|
The Role of AGT in Guiding Therapy of Malignant Glioma
AGT is a human protein that modifies DNA in both normal and tumor cells in order to protect it from damage by certain chemotherapy drugs. In both petri dishes and animal studies, AGT has been observed to prevent the... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
